NCT02471170
Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
Enrolling by Invitation
Not specifiedAges 18+ObservationalAbramson Cancer Center at Penn MedicineInvestigator-initiated
~100 participants
Updated 2026-07-02 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Collection of blood and tissue samples from subjects with pancreatic diseases
Measured over 3 years
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Study leadership
- Peter O'Dwyer, MD · PRINCIPAL_INVESTIGATOR · Abramson Cancer Center at Penn Medicine
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
The subject must be under evaluation and/or treatment for a pancreatic disease
The subject must be under evaluation and/or treatment for a non-pancreatic disease. For example, patients undergoing routine colonoscopy within the clinical practice will be asked to consent to provide control samples. 2. The subject must be able to provide informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf 3. The subject must be 18 years of age or older
What this trial measures
- Collection of blood and tissue samples from subjects with pancreatic diseases3 years